Hong Kong – China Manned Space Exhibition receives its 150 000th visitor (with photos)
China Manned Space Exhibition receives its 150 000th visitor (with photos)
**************************************************************************
The China Manned Space Exhibition, which is being staged at the Hong Kong Science Museum (HKScM) and the Hong Kong Museum of History (HKMH), has received overwhelming response from the local public and tourists since its opening on December 1 last year. The exhibition welcomed its 150 000th visitor today (January 21).
To thank the public for their support to this exhibition which showcases the history and remarkable achievements of China’s manned space development, the Director of Leisure and Cultural Services, Mr Vincent Liu; the Museum Director of the HKScM, Mr Lawrence Lee; and the Museum Director of the HKMH, Mr Ng Chi-wo, warmly greeted the 150 000th visitor and presented an exhibition poster and a gift pack of the Leisure and Cultural Services Department (LCSD) to the visitor today. The 150 000th visitor is from the Liu and Wang families from Chongqing. The two families also visited the exhibition at the National Museum of China in Beijing in July last year. During their visit to Hong Kong this time, they specially arranged to visit the HKScM and the HKMH. Mr Liu expressed his excitement to once again see the return capsule of the Shenzhou manned spacecraft in person, witnessing the swift progress of the nation’s aerospace development. The two ten-year-old girls particularly enjoyed the interactive exhibits in the exhibition.
The exhibition is partitioned into two zones, situated at the HKScM and the HKMH respectively. Within these zones, approximately 30 groups of exhibits are showcased, offering visitors an opportunity to delve deeper into the history and accomplishments of China’s manned space program. The 1/F Main Lobby of the HKMH houses an exhibition area dedicated to the chronicles of China’s manned space development, presenting visitors with a captivating glimpse into the remarkable three-decade journey toward this ambitious goal. On the 2/F Exhibition Hall of the HKScM, visitors can explore noteworthy engineering feats of China’s manned space program and its exhilarating prospects for future development. Highlighted exhibits include the Shenzhou spacecraft return capsule, an intravehicular space suit, a model of the space station, various carrier rocket models such as Long March-2F, Long March-7, Long March-5B, and models of the new-generation manned spacecraft and lunar lander.
The exhibition is jointly presented by the Government of the Hong Kong Special Administrative Region and the China Manned Space Agency, and organised by the LCSD. It will run until February 18 at the HKScM and the HKMH with free admission. For details of the exhibition, please visit hk.science.museum/en/web/scm/exhibition/cmse.html, or call 2732 3232 for enquiries.
HONG KONG, Jan 19, 2024 – (ACN Newswire) – China Resources Corporate Service and SWCS Corporate Services, two renowned professional corporate services providers, jointly announce the successful completion of the acquisition yesterday. More than 100 guests, including Dr. Kenneth LAM, Vice Chairperson of the General Committee of The Hong Kong Listed Companies; Mr. Levin WANG, CEO of Huatai International; Mr. LAN Yi, Vice General Manager of China Resources Group; representatives from the Hong Kong Chinese Enterprises Association, Mainland Chinese enterprises in Hong Kong, industry associations, financial institutions, and professional service organizations, attended the completion ceremony in Hong Kong. At the event, Mr. ZHANG Liqiang, Executive Director, General Manager of China Resources Corporate Service, expressed his gratitude to all the guests. He stated in his speech that China Resources Corporate Service is a new business unit of China Resources Group, focusing on the modern services industry and carrying the significant mission of exploring and laying out modern services in Hong Kong and mainland China. After more than two years of effort, the company now boasts a diversified business portfolio including comprehensive corporate services, supply chain services, and sci-tech services. The acquisition of SWCS Corporate Services signifies China Resources Corporate Service’s commitment to implement China Resources Group’s business strategy in Hong Kong, explore the modern service industry, and develop professional corporate services. Following the acquisition, China Resources Corporate Service will leverage Hong Kong’s unique advantage of “backed by the Motherland, connected to the world,” to focus on customer needs and promote the rapid development of SWCS Corporate Services. Dr. Maurice NGAI, Director and CEO of SWCS Corporate Services, remarked that the acquisition is a significant milestone for the company. Since its establishment in 2011, SWCS Corporate Services has mainly provided mature and top-notch secretarial and compliance services for listed and private companies, while expanding into diversified services such as ESG Reporting and Consultancy, Employee Stock Ownership Plan (ESOP), Private Trust Services, Shareholder Identification Services, and Continuing Professional Development Training Services through the SWCS Academy and other Business Supporting Services. With a deep understanding of mainland corporate culture and the Hong Kong capital market, SWCS Corporate Services has become a preferred professional service provider, leading in secretarial and compliance services for listed companies in Hong Kong and establishing an exceptional corporate image. With the resources from China Resources Corporate Service, SWCS Corporate Services can further enhance its service capabilities to listed companies in the region, expand its influence in Hong Kong and mainland markets, and elevate the company to a new level. Moving forward, both parties will leverage their respective strengths to improve existing professional services, understand the needs of domestic and international corporate clients, continuously expand the professional services market, and contribute to the high-quality development of professional corporate services in Hong Kong and mainland China. About China Resources Corporate Service China Resources Corporate Service Limited is committed to becoming a leading modern service enterprise in Hong Kong and mainland China with significant market influence. The company’s diversified business portfolio includes comprehensive corporate services, supply chain services, and sci-tech services. Its subsidiary has been recognized as a “National High-Tech Enterprise” , and its secretarial service company holds a “Trust or Corporate Service Provider (TCSP)” license. Its intellectual property company was selected as one of the “Top 10 Influential Brands in Chinese Intellectual Property” by the World Brand Lab in 2023. About SWCS Corporate Services SWCS Corporate Services Group (Hong Kong) Limited (SWCS) is a forward-looking professional corporate consulting service provider. Adhering to a client-centric principle, SWCS operates with a cost-effective business model and a unique direct service approach, coupled with exceptional technological services for clients. Whether enterprises are in the pre-listing, listing, or post-listing stages, SWCS can cater to their different needs. Its professional services include company secretarial and compliance, ESG reporting and consultancy (including climate change), family legacy and corporate talent retention, investor relations, SWCS Corporate Academy, and other corporate services. SWCS holds a “Trust or Corporate Service Provider (TCSP)” license. Sectors: Daily Finance http://www.acnnewswire.com Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network. China Medical System Holdings Limited is pleased to announce that according to a notice issued by National Healthcare Security Administration and the Ministry of Human Resources and Social Security of the People’s Republic of China on 13 December 2023, innovative drugs Diazepam Nasal Spray (VALTOCO) and Tildrakizumab Injection (ILUMETRI) and rare disease drug Tetrabenazine Tablets have been newly included in category B of China’s National Reimbursement Drug List for Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance (2023 Version) (the “National Reimbursement Drug List”) and Recombinant Human Brain Natriuretic Peptide for Injection (XinHuoSu) has continued to be included in category B of the National Reimbursement Drug List, which shall be officially implemented from 1 January 2024. In addition, innovative drug Methotrexate Injection (Metoject) indicated for psoriasis approved in March 2023 has been included in category A of the National Reimbursement Drug List. Basic Information of the Products VALTOCO (Diazepam Nasal Spray) VALTOCO has been approved for marketing in China in June 2023. It is the first nasal spray formulation of diazepam in China and the first drug approved in China for the treatment of seizure clusters. VALTOCO is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e. seizure clusters, acute repetitive seizures) that are distinct from a patient’s usual seizure pattern in patients with epilepsy 6 years of age and older. VALTOCO is a proprietary formulation of diazepam administered through the nasal mucosa with high bioavailability, outstanding absorbability, tolerance and reliability. VALTOCO has a unique combination of Vitamin E-based solvents and Intravail® absorption enhancer. Intravail® transmucosal absorption enhancement technology enables the non-invasive delivery of a broad range of proteins, peptides and small-molecule drugs. VALTOCO is administered intranasally. Under prescription from a doctor and guidance from medical staff, VALTOCO can be administered anytime and anywhere with a rapid onset of action. It has the differentiated advantages of seizure rescue and convenient administration, meeting the current clinical need of acute treatment of domestic epilepsy patients with cluster seizures. CMS was assigned the relevant assets of VALTOCO for the exclusive use of such assets in the Territory (mainland China, Hong Kong, Macau, Taiwan, and Singapore) from A&B (HK) Company Limited through an asset assignment and exclusive license agreement with Neurelis, Inc., a U.S. company. ILUMETRI (Tildrakizumab Injection) ILUMETRI has been approved for marketing in China in May 2023. It is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ILUMETRI is a humanized lgG1/κ monoclonal antibody designed to selectively bind to the p19 subunit of interleukin-23 (IL-23) and inhibit its interaction with the IL-23 receptor, leading to inhibition of the release of pro-inflammatory cytokines and chemokines. The results of the extended study of Phase III clinical trial in China demonstrated that the primary efficacy assessment indicator PASI 75 response rate continued to increase over treatment time. The PASI 75 response rate reached a high level after 28 weeks of treatment with ILUMETRI and maintained at 91.3% at week 52, and ILUMETRI showed good long-term safety and tolerance. ILUMETRI only requires 4 administrations per year over maintenance period, which may result in higher patient compliance. CMS obtained an exclusive license for ILUMETRI from Sun Pharmaceutical Industries Ltd. in June 2019. Tetrabenazine Tablets Tetrabenazine Tablets has been approved for marketing in China in May 2023. It is indicated for the treatment of Huntington’s disease. Tetrabenazine tablets, as a first-line drug for Huntington’s disease, is expected to provide another more accessible and affordable drug option for patients with the rare disease. CMS obtained an exclusive license for Tetrabenazine Tablets from Sun Pharmaceutical Industries Ltd. in August 2019. XinHuoSu (Recombinant Human Brain Natriuretic Peptide for Injection) XinHuoSu is the only Recombinant Human Brain Natriuretic Peptide (rhBNP) medicine available in the Chinese market and is indicated for the treatment of acute decompensated heart failure. XinHuoSu can quickly ease the symptoms and signs of heart failure in patients with heart failure and improve the quality of life of patients. It has been recommended by multiple authoritative guidelines and consensus. XinHuoSu is owned and manufactured by a wholly-owned subsidiary of Tibet Rhodiola Pharmaceutical Holding Company (a company listed on the Shanghai Stock Exchange with stock code: 600211) (the “Tibet Pharmaceutical”). CMS holds approximately 37.36% of the shares of Tibet Pharmaceutical. CMS obtained the exclusive sale and distribution right of XinHuoSu from Tibet Pharmaceutical in March 2008. Impacts on the Company CMS actively responds to national policies to promote innovative products to be included in the National Reimbursement Drug List. Up to now, three innovative drugs that have been approved for marketing (VALTOCO, ILUMETRI and Metoject) have all been included in the National Reimbursement Drug List, further improving the accessibility and affordability of the drugs and allowing innovative products to benefit more patients. At the same time, the new/continued inclusion of the four products in the National Reimbursement Drug List will be conducive to promoting the market coverage of the products and building professional brand power, and will have a positive effect on CMS’s business development. Media Contact SCST congratulates Hong Kong, China Delegation on winning five more medals today in Asian Para Games
******************************************************************************************
Mr Yeung said, “Hong Kong, China team athletes are fully committed to give their best and demonstrated their strength and outstanding techniques in winning the medals. Our teams have shown immense team spirit and determination, which means a lot more than the medals they won. We are so proud of them. I wish Hong Kong athletes shine with more accomplishments in the future.”
The Hong Kong, China Delegation has so far won 10 medals, namely two golds, five silvers and three bronzes, at this Asian Para Games. The list of medals won today are as follows:
Silver medal
Wheelchair Fencing: Women’s Team Foil
Lawn Bowls: Men’s B3
Swimming: Mixed 4x100m Freestyle S14
China Communications Construction Company Limited(CCCC), has benefited people all over the world with transportation infrastructure projects oriented to sustainable development, CCCC officials said at a recent forum. The forum, namely 2023 Global Sustainable Transport Forum, was held from Sept. 25 to 26 in Beijing. CCCC was deeply involved in the forum, and organized two side events of the forum. Many senior executives of CCCC attended the forum and side events, and shared information about the group’s achievements in pursuing sustainable transportation at a press conference held by CCCC on Sept. 26. CCCC has expanded its business into five continents and undertaken major projects in 157 countries and regions, including the Mombasa – Nairobi Standard Gauge Railway in Kenya, Hong Kong–Zhuhai–Macao Bridge in south China, and Sri Lanka’s Colombo Port City, strongly boosting economic growth and social prosperity, Wang Tongzhou, Chairman of CCCC, said in his keynote speech delivered at the forum. Committed to “making the world more smooth, making the city more livable, making the life more colorful” CCCC focuses efforts on infrastructure connectivity, common development, innovation-driven development, and eco-friendly construction, and looks forward to enhancing cooperation for shared benefits with all parties, Wang noted. CCCC has actively adapted to the trend toward green economy for years, according to Pei Minshan, Vice General Manager of CCCC. Attaching great importance to China’s carbon peak and neutrality goals, CCCC has accelerated the building of a clean and low-carbon infrastructure system, and pursued energy conservation, pollution control, consumption reduction, and carbon reduction throughout production, operation and management, striving to lay a solid foundation for sustainable transportation, Pei said at the press conference. Innovation is a crucial driving force for the sustainable development of the transportation sector, pointed out Liu Boying, Deputy Chief Engineer of CCCC, at the press conference. CCCC has unswervingly marched along the path of high-quality development driven by innovation, and steadily enhanced independent innovation capacity, Liu said. Tang Qiaoliang, General Manager of CCCC’s Overseas Business Department, shared at the press conference that CCCC has invested in and built over 3,000 high-standard infrastructure projects worth over $140 billion in Belt and Road countries and regions, including over 13,000 kilometers of highways, 3,000 kilometers of railways, over 200 bridges, 150 key ports, 31 newly built or renovated airports, and over 1,000 container bridge cranes. CCCC considers people-to-people connectivity the most profound and long-lasting mode of connectivity, said Tian Jufang, General Manager of CCCC’s Corporate Culture Department. While improving infrastructure, CCCC has carried out assistance activities globally to help improve people’s sense of gain and happiness worldwide, Tian added. Media Contact
China Resources Corporate Service’s Acquisition of SWCS Corporate Services Has Been Completed Successfully
Topic: Press release summary
From the Asia Corporate News Network
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL
Brand: China Medical System Holdings Ltd.
Contact: CMS Investor Relations
Email: ir@cms.net.cn
Website: https://web.cms.net.cn/en/home/
Topic: Press release summaryHong Kong – SCST congratulates Hong Kong, China Delegation on winning five more medals today in Asian Para Games
The Secretary for Culture, Sports and Tourism, Mr Kevin Yeung, today (October 24) congratulated the Hong Kong, China Delegation on winning five more medals at the 4th Asian Para Games Hangzhou.
Gold medal
————–
Swimming: Women’s 100m Backstroke S14
Chan Yui-lam
————–
Wheelchair Fencing: Men’s Team Sabre
Glass Sean
Kwong Yuen-hing
Chan Wing-kin
Yu Chui-yee
Lam Ka-man
Chung Yuen-ping
Fan Pui-shan
Iron Tang
Chan Yui-lam, Cheung Tsun-lok, Tang Wai-lok, Cheung Ho-ying
China Communications Construction Company strives to become model contributor to global sustainable transportation
Wang Yueran, huanqiu.com
Email: wangyueran@huanqiu.com
Website: http://www.huanqiu.com
Tel: 13002252096
Topic: Press release summaryAds
